Medtronic's MiniMed 780G System Secures FDA Approval for Type 2 Diabetes Treatment and Instinct Sensor Integration.

Medtronic's MiniMed 780G system has secured FDA clearance as an interoperable automated glycemic controller with Abbott's Instinct sensor for type 1 diabetes and approval for use in adults with insulin-requiring type 2 diabetes. This represents a significant advancement in the company's efforts to expand the proven performance and outcomes of its MiniMed 780G automated insulin delivery system to more people living with diabetes. The developments are expected to support Medtronic's revenue growth and help a rebound in the stock's performance.